QLQinghong Liu

Qinghong Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qinghong Liu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Honggang Wang

    Department of General Surgery, Taizhou People's Hospital, Taizhou Clinical Medical College of Nanjing Medical University, Taizhou, Jiangsu, China (mainland)

    5 shared publications
  • Jie Zhao

    Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215000, Jiangsu Province, China

    3 shared publications
  • Peiliang Shi

    Model Animal Research Center of Nanjing University, Nanjing, 210089, Jiangsu Province, China

    3 shared publications
  • Jianguo Jiang

    Department of General Surgery, Taizhou People's Hospital, Taizhou Clinical Medical College of Nanjing Medical University, Taizhou, Jiangsu, China (mainland)

    2 shared publications
  • Jianning Dong

    Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

    2 shared publications
  • Lugen Zuo

    Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, No. 305 East Zhongshan Road, Nanjing, Jiangsu, China

    2 shared publications

Latest Publications

  • Laparoscopic Surgery Within an Enhanced Recovery after Surgery (ERAS) Protocol Reduced Postoperative Ileus by Increasing Postoperative Treg Levels in Patients with Right-Side Colon Carcinoma

    by Honggang Wang, Yong Wang, Hailin Xing, Yaxing Zhou, Jie Zhao, Jianguo Jiang, Qinghong Liu

    BACKGROUND:The aim of this study was to determine the effects of laparoscopic surgery within an ERAS program on outcomes and immunological function in patients with a carcinoma in the right colon. MATERIAL AND METHODS:Patient data were acquired from ...


  • Open Access

    Early decrease in postoperative serum albumin predicts severe complications in patients with colorectal cancer after curative laparoscopic surgery

    by Yong Wang, Honggang Wang, Jianguo Jiang, Xiaofei Cao, Qinghong Liu

    Postoperative severe complications are always associated with prolonged hospital stays, increased economic burdens, and poor prognoses in patients with colorectal cancer (CRC). This present study aimed to investigate potential risk factors including serum albumin (Alb) for severe complications in CRC patients. Eligible patients with primary CRC undergoing elective laparoscopic colectomy from July 2015 to July 2017 were included. Postoperative severe complications were defined as grade III and IV according to the Clavien–Dindo classification. ∆Alb was defined as (preoperative Alb − nadir Alb within POD2)/preoperative Alb × 100%. The baseline characteristics, intraoperative data, and laboratory data were obtained from the database for the analysis. Univariate and multivariate logistic regression analyses were utilized for the assessment of the association between risk factors and postoperative severe complications. The predictive value of ∆Alb for postoperative severe complications was evaluated by receiver operating characteristic (ROC) curve analysis. A total of 193 patients were finally included in the analysis data set, of which 38 (19.7%) patients had postoperative severe complications. In the final multivariate logistic regression analysis, ∆Alb was the only independent factor associated with postoperative severe complications (OR 1.66, 95%CI 1.18–2.33, p = 0.003). The area under the curve (AUC) of ∆Alb was 0.916, with the sensitivity and specificity of 0.842 and 0.858 (p < 0.001). The ∆Alb was an independent risk factor for severe complications in CRC patients after curative laparoscopic surgery.


  • Dietary Nondigestible Polysaccharides Ameliorate Colitis by Improving Gut Microbiota and CD4+ Differentiation, as Well as Facilitating M2 Macrophage Polarization

    by Honggang Wang, Yong Wang, Jie Zhao, Jianguo Jiang, Yaxing Zhou, Peiliang Shi, Qinghong Liu, Yueming Sun

    Background: The aim of this study was to investigate the therapeutic mechanism of a specific multifiber mix diet (MF) designed to match the fiber content of a healthy diet in interleukin‐10 knockout (IL‐10−/−) mice with spontaneous chronic colitis displaying similar characteristics to those of human Crohn's disease (CD).Methods: Sixteen‐week‐old IL‐10−/− mice were used for the experiments with MF diet for 4 weeks. Severity of colitis, the composition of the fecal microbiota, expression of Th1/Th17 cells, myeloperoxidase (MPO) concentrations, and inflammatory cytokines and chemokines (tumor necrosis factor‐α [TNF‐α], IL‐6, macrophage inflammatory protein [MIP]‐2, monocyte chemoattractant protein‐1 [MCP‐1], and MIP‐1α), as well as arginase 1 (Arg1) and signal transducers and activators of transcription 6 (STAT6) proteins, were measured at the end of the experiment. In addition, the corresponding metabolites (short‐chain fatty acids) of MF on CD4+CD25+Foxp3+ regulatory T cells (Tregs) were also detected in vivo and in vitro.Results: MF treatment significantly ameliorated colitis associated with decreased lamina propria frequency of Th1/Th17 cells, MPO concentrations, and inflammatory cytokines and chemokines (TNF‐α, IL‐6, MIP‐2, MCP‐1, and MIP‐1α). An increase in gut microbial diversity was observed after MF treatment compared with IL‐10−/− mice, including a significant increase in bacteria belonging to the Firmicutes phylum and a significant decrease in bacteria belonging to the Proteobacteria phylum. Moreover, MF treatment increased the differentiation of CD4+CD25+Foxp3+ Tregs mainly by microbial metabolites butyrate. In addition, Arg1 and STAT6 proteins were also significantly increased after MF treatment.Conclusions: These results shed light on the contribution of MF treatment to the CD mouse model and suggest that MF has potential as a therapeutic strategy for enhancing efficacy in inducing remission in patients with active CD.


    • 15 June 2016
      • Vol. 8  (6) , 2758-66

    Maresin 1 ameliorates iron-deficient anemia in IL-10(-/-) mice with spontaneous colitis by the inhibition of hepcidin expression though the IL-6/STAT3 pathway.

    by Honggang Wang, Peiliang Shi, Chuanjiang Huang, Qinghong Liu

    Approximately 50% of patients with inflammatory bowel disease (IBD) suffer from anemia, which is prevalently caused by iron deficiency. Maresin 1 (MaR1) is a novel docosahexaenoic acid-derived pro-resolving agent that promotes the resolution of inflammation. The aim of the present study was to investigate the therapeutic effects of MaR1 on iron-deficient anemia in IL-10 knockout (IL-10(-/-)) mice with spontaneous chronic colitis. IL-10(-/-) mice of 16 weeks of age with established colitis were used for the experiments with MaR1 treatment for 2 weeks. Histologic injury, CD4+ lymphocyte values in the lamina propria, blood hemoglobin, hematocrit, serum iron concentrations, transferrin saturation, splenic iron stores, levels of inflammatory cytokines, expression of liver hepcidin mRNA, and western blotting of STAT3 were analyzed in this study. MaR1 treatment (0.3 ng/mouse) effectively attenuated histological colitis typically associated with decreased CD4+ lymphocytes in the lamina propria as well as the concentrations of MPO, TNF-α, IFN-γ, IL-6 and IL-17 (P<0.05). Furthermore, reduced expression of liver hepcidin mRNA and p-STAT3 expression, as well as increased hemoglobin concentration, hematocrit, levels of serum iron, transferrin saturation and splenic iron stores were found in IL-10(-/-) mice after MaR1 treatment (P<0.05). These results indicate that MaR1 treatment ameliorates iron-deficient anemia by reducing colonic inflammation and inhibiting hepcidin expression though the IL-6/STAT3 pathway.


  • Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn’s Disease

    by Honggang Wang, Lugen Zuo, Jie Zhao, Jianning Dong, Yi Li, Lili Gu, Jianfeng Gong, Qinghong Liu, Weiming Zhu

    Background: The impact of preoperative enteral nutrition (EN) on postoperative complications and recurrence in Crohn’s disease (CD) has not been investigated to date. The purpose of the present study was to determine the effect of preoperative exclusive EN on postoperative complications and recurrence after bowel resection in patients with active CD.Methods: Patient data were obtained from a prospectively maintained database. 81 patients who received bowel resection for ileal or ileocolonic CD were studied. Before operation, 42 CD patients received exclusive EN for 4 weeks, and the other patients had no nutritional therapy. All patients were followed up regularly for 2 years after surgery, and ileocolonoscopy was performed every 6 months after bowel resection.Results: Patients receiving exclusive EN had a dramatic improvement of nutritional (BMI, albumin, pre‐albumin, and Hb) and inflammatory (CRP and CDAI) status compared with baseline after the EN therapy for 4 weeks (P < 0.05). Furthermore, significantly lower incidence of both infectious and non‐infectious complications was observed in patients receiving exclusive EN compared with those received no nutritional therapy (P < 0.05). Exclusive EN therapy for 4 weeks significantly reduced endoscopic recurrence rates after resection for CD 6 months after operation. However, during the 2‐year follow‐up, incidence of clinical recurrence was similar in both groups (P > 0.05).Conclusions: Preoperative exclusive EN therapy for 4 weeks reduced postoperative complications, which may be associated with improvement of nutritional and inflammatory status in patients with active CD.


  • Open Access

    Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice

    by Honggang Wang, Peiliang Shi, Lugen Zuo, Jianning Dong, Jie Zhao, Qinghong Liu, Weiming Zhu

    Enteral nutrition [EN] was reported to be as effective as steroids in achieving short-term remission in patients with Crohn’s disease [CD], and exclusive EN [EEN] is widely used as primary therapy in children with CD. The aim of this study was to investigate the effect of a specific multi-fibre mix [MF], designed to match the fibre content of a healthy diet, on intestinal epithelial barrier function in IL-10 knockout [IL-10 −/− ] mice with spontaneous chronic colitis. IL-10 −/− mice aged 16 weeks, with established colitis, were used for the experiments with multi-fibre mix diet [MF] for 4 weeks. Severity of colitis, levels of short cahin fatty acids [SCFA] in caecum contents, expression of STAT 3 and STAT 4 proteins, CD4 + CD45 + lymphocytes, CD4 + Foxp3 + regulatory T cells [Tregs] and cytokines in the lamina propria [LP], epithelial expression of tight junction proteins, TNF-α/TNFR2 mRNA expression, and epithelial apoptosis in the proximal colon were measured at the end of the experiment. MF feeding effectively attenuated disease activity index and colitis associated with decreased lamina propria CD4 + CD45 + lymphocytes, IFN-γ/IL-17A mRNA expression, and p-STAT 3 and p-STAT 4 expression in colonic mucosa of IL-10 −/− mice [ p < 0.05]. Furthermore, CD4 + Foxp3 + Tregs in the LP and concentrations of total SCFA, acetate, propionate, and butyrate in the caecum were markedly increased after MF feeding in IL-10 −/− mice. After MF feeding, increased epithelial expression and correct localisation of tight junction proteins [occludin and zona occludens protein 1], as well as reduced TNF-α/TNFR2 mRNA expression and epithelial apoptosis, were also observed in IL-10 −/− mice. These results indicated that EEN supplemented with the tested fibre mix, known to modulate the intestinal microbiota composition and SCFA production, could possibly improve efficacy in inducing remission in patients with active CD.